For the Inventor, By the Inventor

Enter assignee name

Culver City, CA, United States of America

Nantomics, LLC

USPTO Granted Patents = 64

CIPO Patents = 2

EPO Patents = 16

Forward Citations = 133

Loading Chart...

Loading Chart...

38 inventors (with patents filed for the assignee):

Stephen Charles Benz (31 out of 54 patents)

Shahrooz Rabizadeh (30 out of 82 patents)

Patrick Soon-Shiong (25 out of 450 patents)

4. Kayvan R Niazi (15 out of 90 patents)

5. Bing Song (14 out of 77 patents)

6. Andrew Nguyen (14 out of 179 patents)

7. John Zachary Sanborn (13 out of 59 patents)

8. Christopher W Szeto (13 out of 13 patents)

9. Liudmila A Beziaeva (11 out of 11 patents)

10. Mustafa Jaber (9 out of 21 patents)

11. Charles Joseph Vaske (8 out of 30 patents)

12. Nicholas James Witchey (5 out of 147 patents)

13. Kamil A Wnuk (5 out of 45 patents)

14. Rahul Chaturvedi (4 out of 18 patents)

15. Paul Weingarten (4 out of 10 patents)

Core Competencies:

Tumor HLA Mutation

Deep Learning Models

Digital Histopathology

Immunotherapy Markers

Cancer Neoepitopes

Genome Sequence Data

Real-Time Pathology Imaging

Synthetic Genomic Variants

Weakly Supervised Learning

Cancer Score Assessment

Viral Neoepitopes

Pathway Analysis

64 patents: Sort by Forward Citations

1. 12518214 - Distributed machine learning systems including generation of synthetic data (2026-01-06),

2. 12487240 - Tumor HLA mutation versus matched normal HLA (2025-12-02),

3. 12412639 - Method of characterizing a tumor based on an immune gene expression signature in regulatory T cell (Treg)-enriched tumor samples (2025-09-09),

4. 12406366 - Real-time whole slide pathology image cell counting (2025-09-02),

5. 12404490 - AGGF1 immunogenic compositions (2025-09-02),

6. 12224066 - Deep learning models for region of interest determination (2025-02-11),

7. 12224064 - Deep learning models for tumor evaluation (2025-02-11),

8. 12205678 - Genome explorer system to process and present nucleotide variations in genome sequence data (2025-01-21),

9. 12205033 - Weakly supervised learning with whole slide images (2025-01-21),

10. 12195808 - Dynamic changes in circulating free RNA of neural tumors (2025-01-14),

11. 12170142 - Classification based on characterization analysis methods and systems (2024-12-17),

12. 12094574 - Difference-based genomic identity scores (2024-09-17),

13. 12080382 - Viral neoepitopes and uses thereof (2024-09-03),

14. 12053512 - Method of validating the triggering of an immune response to a neoepitope of a tumor with t-cells (2024-08-06),

15. 12052240 - Synthetic genomic variant-based secure transaction devices, systems and methods (2024-07-30),

NantOmics, LLC, is a leading precision medicine company dedicated to transforming cancer care through innovative molecular diagnostics. They develop and provide cutting-edge molecular testing and bioinformatics services to help physicians and researchers understand and treat cancer more effectively. With a focus on personalized medicine, NantOmics uses advanced sequencing technologies and artificial intelligence to analyze the molecular profile of tumors and provide actionable insights for personalized treatment decisions. They are committed to revolutionizing cancer care and improving patient outcomes through their state-of-the-art technologies and expertise.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

64 Patents

#5 in Culver City, CA

#1,293 in California

#5,507 in US

#11,202 in the World

Culver City, CA, United States of America

Nantomics, LLC

Forward Citations = 133

38 inventors:

Stephen Charles Benz (31 out of 54 patents)

Shahrooz Rabizadeh (30 out of 82 patents)

Patrick Soon-Shiong (25 out of 450 patents)

4. Kayvan R Niazi (15 out of 90 patents)

5. Bing Song (14 out of 77 patents)

Please report any incorrect information to support@idiyas.com

Loading…